Skip to content
10-Q

Quarterly Report

INNOVATION1 BIOTECH INC.

0001753926-25-000149

← back to feed
Filed
Jan 27, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Jan 27, 2025 22.47M sh
Operating Cash Flow Q1 2023 · Nov 30, 2023 $150.92K
Operating Cash Flow restated Q1 2023 · Nov 30, 2022 $195.24K
Cash And Equivalents Q1 2023 · Nov 30, 2023 $5.82K
Cash And Equivalents Q1 2023 · Aug 31, 2023 $49.85K
Stockholders Equity Q1 2023 · Nov 30, 2023 −$3.05M
Stockholders Equity Q1 2023 · Aug 31, 2023 −$3.43M
Stockholders Equity restated Q1 2023 · Nov 30, 2022 $2.08M
Stockholders Equity Q1 2023 · Aug 31, 2022 $2.85M
Current Liabilities Q1 2023 · Nov 30, 2023 $2.66M
Current Liabilities Q1 2023 · Aug 31, 2023 $3.29M
Total Liabilities Q1 2023 · Nov 30, 2023 $3.07M
Total Liabilities Q1 2023 · Aug 31, 2023 $3.51M
Current Assets Q1 2023 · Nov 30, 2023 $17.07K
Current Assets Q1 2023 · Aug 31, 2023 $72.74K
Total Assets Q1 2023 · Nov 30, 2023 $20.06K
Total Assets Q1 2023 · Aug 31, 2023 $75.99K
Sga Expense Q1 2023 · Nov 30, 2023 $13.45K
Sga Expense Q1 2023 · Nov 30, 2022 $161.01K
Rd Expense Q1 2023 · Nov 30, 2023 $0
Rd Expense Q1 2023 · Nov 30, 2022 $15K
Net Income Q1 2023 · Nov 30, 2023 −$255.23K
Net Income Q1 2023 · Nov 30, 2022 −$631.67K
Operating Income Q1 2023 · Nov 30, 2023 $155.83K
Operating Income restated Q1 2023 · Nov 30, 2022 $628.82K
Gross Profit Q1 2023 · Nov 30, 2023 $0
Gross Profit Q1 2023 · Nov 30, 2022 $0
Cost Of Revenue Q1 2023 · Nov 30, 2023 $0
Cost Of Revenue Q1 2023 · Nov 30, 2022 $0
Revenue Q1 2023 · Nov 30, 2023 $0
Revenue Q1 2023 · Nov 30, 2022 $0